RecruitingNot ApplicableNCT05116514

Evaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 16 to 30 Years With a First Psychotic Episode.

Evaluation of the Impact of Case Manager Intervention on the 3-year Psychotic Episode Recurrence Rate in Patients Aged 16 to 30 Years With a First Psychotic Episode. Randomized, Open-label, Multicenter Controlled Study With Blinded Evaluation.


Sponsor

Centre Hospitalier Universitaire de Nīmes

Enrollment

256 participants

Start Date

Sep 27, 2021

Study Type

INTERVENTIONAL

Conditions

Summary

The study investigators hypothesize that the intervention of case managers specifically trained in case management of early psychosis will change the paradigm of care of a first psychotic episode from the current organization of the care system. Indeed, the creation of specific services for emerging psychotic disorders cannot easily be generalized throughout the country and requires specific funding. The intervention of case managers according to the recommendations of good practices will make it possible to propose the fundamental principles of early intervention to young patients and their families on a large scale throughout the territory, namely: personalized and proactive accompaniment, psycho-education of the pathology and treatments, involvement and support of the families, and support for socio-professional reintegration


Eligibility

Min Age: 16 YearsMax Age: 30 Years

Inclusion Criteria9

  • The patient or their close relative must have given their free and informed consent and signed the consent form
  • The patient must be a member or beneficiary of a health insurance plan
  • The patient is available for a 3-year follow-up.
  • Patient is managed in a psychiatric service (consultation or hospitalization) for a first episode psychosis defined by:
  • Presence of positive psychotic symptoms (delusion(s) and/or hallucination(s) and/or conceptual disorganization) evolving for at least one week, either daily or at least 3 times per week for at least one hour per occasion ;
  • Never having taken a neuroleptic treatment with antipsychotic aim (except for an antipsychotic treatment started for the current episode for example by the general practitioner before being referred to psychiatry);
  • A disorder meeting the DSM 5 criteria from the following list: delusional disorder, brief psychotic disorder greater than 7 days, schizophreniform disorder, schizophrenia, schizoaffective disorder, substance-induced psychotic disorder greater than 7 days, other specific or nonspecific schizophrenic spectrum disorder or other psychotic disorder, bipolar I or II disorder with congruent and non-mood congruent psychotic features, bipolar disorder with congruent and non-mood congruent psychotic features induced by a substance, major depressive disorder with congruent and non-mood congruent psychotic features.
  • Inclusion should be within the first 3 months of care for first episode psychosis in the psychiatric service.
  • At the time of inclusion, the psychotic symptomatology observed during the first episode psychosis may still be present or in remission.

Exclusion Criteria7

  • The subject is participating in another category I interventional study, or is in a period of exclusion determined by a previous study
  • The subject, or one of the parents for minor patients, refuses to sign the consent
  • It is impossible to give the subject informed information
  • The patient is under safeguard of justice or state guardianship
  • The patients has an IQ less than or equal to 55
  • The patient has a first psychotic episode linked to a psychotic problem triggered by a medication of other medical condition
  • The patient is pregnant or breastfeeding

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCase management

Regular and personalized follow-up by a case manager using a "case management" approach, updated every 3 months


Locations(6)

CHU de TOULOUSE

Toulouse, Choisir Une Région, France

CH Saint Marie Clermont-Ferrand

Clermont-Ferrand, France

CHU de Montpellier

Montpellier, France

CHU Nice

Nice, France

CHU de Nîmes

Nîmes, France

Centre Hospitalier Léon-Jean Grégory

Thuir, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05116514


Related Trials